NEW YORK (GenomeWeb) – Signal Genetics said after the close of the market on Thursday that its first quarter revenues dropped 41 percent year over year. 

The Carlsbad, California-based molecular diagnostics firm recorded $645,000 in revenues for the three months ended March 31, down from $1.1 million in the year-ago quarter. The firm said that the decrease was driven by a drop in the number of tests billed for University of Arkansas for Medical Sciences research and clinical patients at the hospital. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.